Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer
Authors:
- A K AnandAAA K Anand
- A R ChaudhooryACA R Chaudhoory
- A ShuklaASA Shukla
- P S NegiPNP S Negi
- S N SinhaSSS N Sinha
- A A G BabuABA A G Babu
- R K MunjalRMR K Munjal
- A K DewanADA K Dewan
- K KumarKKK Kumar
- D C DovalDDD C Doval
- A K VaidAVA K Vaid
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 81 (971) , 865-871
Abstract
The aim of this study was to evaluate the impact of intensity-modulated radiation therapy (IMRT) on the incidence and severity of chronic dysphagia in patients with head and neck cancer. 62 evaluable patients with head and neck cancer who were treated with IMRT with or without concurrent chemotherapy were analysed. The majority of the patients (77.4%) had advanced locoregional disease. 45 patients underwent definitive IMRT and 17 received post-operative IMRT. Concurrent chemotherapy was given to 29 of the 45 patients treated with definitive IMRT. The average prescribed dose to clinical target volume (CTV)1 was 66–70 Gy (definitive IMRT) and 56–62 Gy (post-operative IMRT); 60 Gy to CTV2; 54 Gy to CTV3; and 50–52 Gy to the supraclavicular area. At a median follow-up of 19 months, 2-year actuarial locoregional control and survival was 77% and 74%, respectively. At 6 months after IMRT, chronic dysphagia was Grade 0 in 77.1% of patients, Grade 1 in 10.5% and Grade 2 in 12.3%. Acute mucositis showed no correlation with long-term dysphagia. The percutaneous endoscopic gastrostomy or nasogastric tube was removed in all of the patients within 8 weeks of completion of treatment. Xerostomia was Grade 0 in 61.4% of patients, Grade 1 in 31.5% and Grade 2 in 7% of patients. In conclusion, IMRT conferred a major favourable impact on chronic dysphagia in patients with locally advanced head and neck cancers, with satisfactory locoregional control.Keywords
This publication has 23 references indexed in Scilit:
- Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck CancerJournal of Clinical Oncology, 2006
- Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- An evaluation of patterns of failure and subjective salivary function in patients treated with intensity-modulated radiotherapy for head and neck cancersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Intensity modulation delivery techniques: “Step & shoot” MLC auto‐sequence versus the use of a modulatorMedical Physics, 2000
- Long-term Swallowing Problems After Organ Preservation Therapy With Concomitant Radiation Therapy and Intravenous HydroxyureaJAMA Otolaryngology–Head & Neck Surgery, 2000
- What else don't we know about the late effects of radiation in patients treated for head and neck cancer?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- A functional evaluation of patients treated for oral cancer. A prospective studyInternational Journal of Oral and Maxillofacial Surgery, 1993